Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Meet Our Editorial Board Member
Volume: 17 Issue: 1
Author(s): Fabrizio Bruschi*
Affiliation:
- Universita di Pisa Pisa,Italy
Export Options
About this article
Cite this article as:
Bruschi Fabrizio*, Meet Our Editorial Board Member, Endocrine, Metabolic & Immune Disorders - Drug Targets 2017; 17 (1) . https://dx.doi.org/10.2174/187153031701170623161009
DOI https://dx.doi.org/10.2174/187153031701170623161009 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
12
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synaptic and Extrasynaptic Glutamate Signaling in Ischemic Stroke
Current Medicinal Chemistry Beneficial Effects of Herbs, Spices and Medicinal Plants on the Metabolic Syndrome, Brain and Cognitive Function
Central Nervous System Agents in Medicinal Chemistry Riboregulators and Metabolic Disorders: Getting Closer Towards Understanding the Pathogenesis of Diabetes Mellitus?
Current Molecular Medicine Emerging Therapy for Diabetic Neuropathy: Cell Therapy Targeting Vessels and Nerves
Endocrine, Metabolic & Immune Disorders - Drug Targets Patent Selections:
Recent Patents on Biomarkers Liver-Directed Gene Therapy with Helper-Dependent Adenoviral Vectors: Current State of the Art and Future Challenges
Current Pharmaceutical Design Oxytocin and Eating Disorders: A Narrative Review on Emerging Findings and Perspectives
Current Neuropharmacology Cellular Mechanisms of Brain Injury and Cell Death
Current Pharmaceutical Design Radiopharmaceuticals, Drug Development and Pharmaceutical Regulations in Europe
Current Radiopharmaceuticals PACAP is Implicated in the Stress Axes
Current Pharmaceutical Design Low Grade Inflammation as a Common Pathogenetic Denominator in Age-Related Diseases: Novel Drug Targets for Anti-Ageing Strategies and Successful Ageing Achievement
Current Pharmaceutical Design Communication Factors-Promising Targets in Osteoporosis Treatment
Current Drug Targets Study of Cord Blood Erythropoietin, Leptin and Adiponectin Levels in Neonates with Hypoxic Ischemic Encephalopathy
Endocrine, Metabolic & Immune Disorders - Drug Targets Recombinant Antibodies in Cancer Therapy
Current Protein & Peptide Science Personalized Medicine and Molecular Diagnostics for Obesity: Metabolic Systems Reconstruction and Gut Microbiome Biomarkers
Current Pharmacogenomics and Personalized Medicine Editorial: Advances in Alzheimer Therapy: Something Old, Something New, Something Borrowed, Something Blue
Current Alzheimer Research Chlamydia-Secreted Proteins in Chlamydial Interactions with Host Cells
Current Chemical Biology The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases
Current Neuropharmacology Sonic Hedgehog Signaling Activation Promotes Cardioprotective Strategies
Current Signal Transduction Therapy Type 2 Transglutaminase in Neurodegenerative Diseases: The Mitochondrial Connection
Current Pharmaceutical Design